SCHEMBL104727

SCHEMBL104727

Cc1ccccc1OC(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.48
NISCH Q9Y2I1 1/20 0.47
ACHE P22303 2/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 5/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
SLC6A2 P23975 5/20 0.44
SLC6A4 P31645 4/20 0.44
SLC6A3 Q01959 4/20 0.44
CYP1A2 P05177 4/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 3/20 0.44
CHRM1 P11229 2/20 0.44
ADRA2B P18089 2/20 0.44
HTR2A P28223 2/20 0.44
HTR2C P28335 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31490450 1.00 IRAK4 (0.48) IRAK4NISCHACHEALDH1A1TSHR
SCHEMBL28883167 0.98 IRAK4 (0.47) IRAK4NISCHACHEALDH1A1TSHR
Ammonia Solution, Strong SCHEMBL5891986 0.98 IRAK4 (0.47) IRAK4NISCHACHEALDH1A1TSHR
Hydrochloric Acid SCHEMBL4624005 0.98 IRAK4 (0.47) IRAK4NISCHACHEALDH1A1TSHR
SCHEMBL28700751 0.91 IRAK4 (0.43) IRAK4NISCHACHEALDH1A1TSHR
Formic Acid SCHEMBL28111659 0.88 IRAK4 (0.49) IRAK4NISCHACHEALDH1A1TSHR
SCHEMBL1592873 0.85 NISCH (0.47) NISCHACHETSHRKMT2AMEN1
SCHEMBL29591819 0.84 ALDH1A1 (0.57) IRAK4NISCHACHEALDH1A1KMT2A
SCHEMBL2069775 0.84 ALDH1A1 (0.57) IRAK4NISCHACHEALDH1A1KMT2A
SCHEMBL28911420 0.82 TSHR (0.46) NISCHACHEALDH1A1TSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 326 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107840902-B Preparation method of reinforcing plasticizer for nitrile rubber 中国石油天然气股份有限公司 2020-09-04 CN claimed
CN-107841007-B Preparation method of easily processed reinforced nitrile rubber 中国石油天然气股份有限公司 2020-09-04 CN claimed
CN-107540896-B Preparation method of easily-processed flame-retardant nitrile rubber 中国石油天然气股份有限公司 2020-09-04 CN claimed
CN-107540893-B Easily-processed flame-retardant nitrile rubber and preparation method thereof 中国石油天然气股份有限公司 2020-09-04 CN claimed
CN-107841009-B Easily-processed anti-aging styrene butadiene rubber and preparation method thereof 中国石油天然气股份有限公司 2020-09-04 CN claimed
CN-107841010-B Preparation method of easy-to-process reinforced styrene butadiene rubber 中国石油天然气股份有限公司 2020-09-04 CN claimed
CN-107841004-B Preparation method of easily-processed anti-aging nitrile rubber 中国石油天然气股份有限公司 2020-09-04 CN claimed
CN-107841006-B Easily-processed anti-aging nitrile rubber and preparation method thereof 中国石油天然气股份有限公司 2020-08-07 CN claimed
CN-107841011-B Preparation method of easily-processed anti-aging styrene butadiene rubber 中国石油天然气股份有限公司 2020-08-07 CN claimed
CN-107841008-B Easily-processed reinforced styrene butadiene rubber and preparation method thereof 中国石油天然气股份有限公司 2020-08-07 CN claimed
CN-107841005-B Easily-processed reinforced nitrile rubber and preparation method thereof 中国石油天然气股份有限公司 2020-08-07 CN claimed
CN-107840903-B Preparation method of reinforced softener for styrene butadiene rubber 中国石油天然气股份有限公司 2020-08-07 CN claimed
CN-107540765-B Preparation method of flame-retardant plasticizer for nitrile rubber 中国石油天然气股份有限公司 2020-06-09 CN claimed
CN-104430357-A Bactericide composition containing coumoxystrobin with synergistic effect JILIN BADA PESTICIDE CO LTD 2015-03-25 CN claimed
US-8088797-B2 Substituted N-(4-cyano-1H-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-01-03 US claimed
US-20100041709-A1 SUBSTITUTED N-(4-CYANO-1H-PYRAZOL-3-YL)METHYLAMINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-02-18 US claimed
EP-0365328-B1 Pyridine derivatives ZENECA LTD (GB) 1996-04-03 EP claimed
US-5053415-A Antiischemic, antiinflammatory, antiarthritic agents, cardiovascular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-10-01 US claimed
EP-0365328-A2 Pyridine derivatives ZENECA LIMITED (GB) 1990-04-25 EP claimed
EP-0069906-A2 Water-based aerosol formulations BAYER AG (DE) 1983-01-19 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041709-A1 SUBSTITUTED N-(4-CYANO-1H-PYRAZOL-3-YL)METHYLAMINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF PRMT3, PRMT5, PRMT1 IRAK4 898/4885NISCH 1583/4885ACHE 320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.